4-carboxy-3-hydroxyphenylglycine has been researched along with Ischemic Attack, Transient in 1 studies
4-carboxy-3-hydroxyphenylglycine: weak agonist at metabotropic glutamate receptors; occludes the action of 1-aminocyclopentyl-1,3-dicarboxylate in hippocampus
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rauca, C | 1 |
| Henrich-Noack, P | 1 |
| Schäfer, K | 1 |
| Höllt, V | 1 |
| Reymann, KG | 1 |
1 other study available for 4-carboxy-3-hydroxyphenylglycine and Ischemic Attack, Transient
| Article | Year |
|---|---|
(S)-4C3HPG reduces infarct size after focal cerebral ischemia.
Topics: Animals; Cerebral Infarction; Cerebral Ventricles; Glycine; Injections, Intraventricular; Ischemic A | 1998 |